α
AlphaScala
StocksSignalsNEWAlpha ScoreBriefingsNEWBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsMarket BriefingsAlpha ScoreHedge Funds 13FInsider BuysPolitician TradesAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutMethodologyEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala – Built with data, not hype.
All Stocks/Healthcare/CRL

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
HealthcareDiagnostics & Research Website
Signal SnapshotMarket signals →
Alpha Score
Score pending
Alpha Score appears once the required price and fundamentals data has ingested.
Daily model
Insiders
No recent signal
No recent open-market insider buying or selling is in the current rollup.
Form 4
13F Holder
Citadel
$88.93M reported position; latest action: new.
Ken Griffin
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about CRLAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
446K$88.93MNEW
D.E. Shaw
David Shaw
431K$86.00MNEW
Point72
Steve Cohen
222K$44.20MNEW
Marshall Wace124K$24.77MNEW
Renaissance Technologies
Jim Simons (founder)
10K$2.03MNEW
Soros Fund Management
George Soros (founder)
7K$1.35MNEW
Explore all tracked funds →
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Charles River Laboratories International, Inc. is a leading provider of essential products and services that support pharmaceutical, biotechnology, and medical device companies in drug discovery, development, and manufacturing. It operates through three core segments: Research Models and Services, which supplies specialized animal models, insourcing solutions, and accelerator and development labs for preclinical research; Discovery and Safety Assessment, delivering regulatory-required safety testing for new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices; and Manufacturing Solutions, offering microbial solutions for in vitro testing and biologics solutions including testing services and avian vaccines. These offerings enable clients to advance therapies from early discovery through safety validation and production support, playing a critical role in the preclinical and clinical stages of the life sciences industry. Founded in 1947 and headquartered in Wilmington, Massachusetts, Charles River Laboratories International, Inc. serves a global market with a focus on high-quality, compliant research and testing services.

CEO
Mr. James C. Foster J.D.
Employees
18,300
Quick Facts
Exchange–
SectorHealthcare
IndustryDiagnostics & Research
Market Cap–
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when CRL reports next.

Get earnings alerts →